OTC · Financial Statements
Biophytis S.A. (BPTSY) Financial Statements
$0.25
OTC: BPTSY
Market Cap $105224
Overview Financials Dividend
Biophytis S.A. most recently reported annual revenue of $0, a net loss of $10.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2020 2021 2022 2023 2024
Revenue $0 $0 $0 $0 $0 Operating Profit $-14.0M $-27.0M $-23.0M $-14.0M $-8.0M Net Profit $-26.0M $-31.0M $-24.0M $-17.0M $-10.0M EPS $-1701.90 $-1053.80 $-554.00 $-125.40 $-2.00 Op Margin — — — — —
Balance Sheet (USD)
Metric 2020 2021 2022 2023 2024
Total Assets $27.0M $35.0M $22.0M $12.0M $7.0M Total Liabilities $25.0M $29.0M $24.0M $16.0M $17.0M Cash $6.0M $24.0M $11.0M $6.0M $0 Borrowings $15.0M $17.0M $12.0M $8.0M $10.0M
Cash Flow (USD)
Metric 2020 2021 2022 2023 2024
Operating Cash Flow $-10.0M $-24.0M $-19.0M $-13.0M $-9.0M Investing Cash Flow $-13.0M $12.0M $0 $0 $10.0M Financing Cash Flow $-4.0M $-4.0M $-1.0M $0 $0 Net Cash Flow $0 $18.0M $-13.0M $-5.0M $-5.0M Free Cash Flow $-10.0M $-24.0M $-19.0M $-13.0M $-9.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.00 EV / EBITDA -1.27 FCF Yield -1211.89% Quick Ratio 0.25 Interest Coverage -9.75 Return 1Y -86.15% Return 3Y -99.55% Return 5Y -99.99%
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer .